We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XENT
1951
DELISTED
Intersect ENT, Inc
XENT
| $1.11M | ﹤0.01% |
39,547
+12,700
| +47% | +$372K |
|
1952
HCI Group
HCI
$2.31B
| $1.11M | ﹤0.01% |
21,912
+3,460
| +19% | +$169K |
|
|
MRTX
1953
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.11M | ﹤0.01% |
26,241
+9,385
| +56% | +$374K |
|
1954
Columbia Financial
CLBK
$1.13B
| $1.11M | ﹤0.01% |
72,727
+23,637
| +48% | +$370K |
|
|
AKRX
1955
DELISTED
Akorn Inc
AKRX
| $1.11M | ﹤0.01% |
327,768
+100,602
| +44% | +$598K |
|
|
RAD
1956
DELISTED
Rite Aid Corporation
RAD
| $1.11M | ﹤0.01% |
78,077
+22,541
| +41% | +$475K |
|
1957
ANI Pharmaceuticals
ANIP
$1.88B
| $1.1M | ﹤0.01% |
24,339
+3,642
| +18% | +$191K |
|
|
CBB
1958
DELISTED
Cincinnati Bell Inc.
CBB
| $1.1M | ﹤0.01% |
140,845
+24,008
| +21% | +$294K |
|
|
TRUE
1959
DELISTED
TrueCar
TRUE
| $1.09M | ﹤0.01% |
120,482
+40,351
| +50% | +$436K |
|
|
NWLI
1960
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.09M | ﹤0.01% |
3,615
+755
| +26% | +$221K |
|
|
UBNK
1961
DELISTED
United Financial Bancorp, Inc.
UBNK
| $1.09M | ﹤0.01% |
73,867
+21,872
| +42% | +$345K |
|
1962
NeoGenomics
NEO
$2B
| $1.08M | ﹤0.01% |
85,900
+31,639
| +58% | +$472K |
|
1963
Lattice Semiconductor
LSCC
$18.3B
| $1.08M | ﹤0.01% |
156,333
+53,766
| +52% | +$362K |
|
|
EXPR
1964
DELISTED
Express, Inc.
EXPR
| $1.08M | ﹤0.01% |
10,580
+1,479
| +16% | +$228K |
|
1965
Century Aluminum
CENX
$4.55B
| $1.08M | ﹤0.01% |
147,655
+24,186
| +20% | +$219K |
|
|
RCM
1966
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.08M | ﹤0.01% |
135,458
+44,144
| +48% | +$381K |
|
1967
Acco Brands
ACCO
$407M
| $1.08M | ﹤0.01% |
158,691
+44,556
| +39% | +$381K |
|
|
HOME
1968
DELISTED
At Home Group Inc.
HOME
| $1.08M | ﹤0.01% |
57,657
+20,005
| +53% | +$509K |
|
1969
Unitil
UTL
$981M
| $1.07M | ﹤0.01% |
21,153
+6,875
| +48% | +$343K |
|
1970
Acushnet Holdings
GOLF
$5.5B
| $1.07M | ﹤0.01% |
50,798
+15,389
| +43% | +$367K |
|
|
SHOE
1971
Shoe Station Group
SHOE
$425M
| $1.07M | ﹤0.01% |
63,778
+9,826
| +18% | +$182K |
|
|
NRE
1972
DELISTED
NorthStar Realty Europe Corp.
NRE
| $1.07M | ﹤0.01% |
73,406
+19,212
| +35% | +$283K |
|
|
FRGI
1973
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $1.06M | ﹤0.01% |
68,580
+11,589
| +20% | +$253K |
|
1974
Virtu Financial
VIRT
$4.91B
| $1.06M | ﹤0.01% |
41,177
+2,796
| +7% | +$67.4K |
|
1975
Smith & Wesson
SWBI
$651M
| $1.05M | ﹤0.01% |
106,525
+30,532
| +40% | +$317K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.